Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy

Shuilong Leng1, Yanli Hao, Daobing Du

  • 1Department of Human Anatomy, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Insights

Ursolic acid (UA) triggers autophagy, a cell-death process, in cervical cancer cells, reducing tumor growth. This autophagy, mediated by Atg5, offers a new therapeutic strategy for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Ursolic acid (UA) exhibits anticancer properties, but its mechanisms remain unclear.
  • While some UA anticancer effects are linked to apoptosis, this study explores alternative pathways.
  • Cervical cancer remains a significant health concern, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To investigate the role of autophagy in the anticancer effects of ursolic acid (UA) on TC-1 cervical cancer cells.
  • To determine whether UA-induced cell death occurs via apoptosis or autophagy.
  • To identify key autophagy-related genes involved in UA's mechanism of action.

Main Methods:

  • TC-1 cells and mouse embryonic fibroblast (MEF) cells (Atg5+/+ and Atg5-/-) were treated with UA.
  • Apoptosis was assessed using Annexin V/propidium iodide staining, DNA fragmentation, and Western blotting.
  • Autophagy was evaluated by monitoring LC3 (microtubule-associated protein 1A/1B-light chain 3) puncta, LC3II levels, and transmission electron microscopy.
  • Inhibitors like wortmannin and gene silencing (siRNA for Atg5 and BECN1) were employed to modulate autophagy pathways.

Main Results:

  • UA treatment induced autophagy, evidenced by increased LC3 puncta and LC3II levels in TC-1 cells, without inducing apoptosis.
  • Autophagy inhibition (wortmannin or Atg5 siRNA) reduced UA-induced cytotoxicity and LC3II expression.
  • MEF cells lacking Atg5 (Atg5-/-) showed significantly reduced LC3II and increased survival upon UA treatment compared to wild-type MEF cells.
  • Silencing BECN1 did not affect UA-induced autophagy or cell survival.

Conclusions:

  • Autophagy, specifically dependent on Atg5, is a primary mechanism for UA-induced cell death in TC-1 cervical cancer cells.
  • UA-induced autophagic cell death presents a potential therapeutic strategy, distinct from apoptosis-based treatments.
  • Targeting Atg5 may enhance the efficacy of ursolic acid in cancer therapy.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...